TRPM8 and prostate carcinoma: Next, we examined whether TRPM8 were attenuated in ROS-induced apoptosis, cell viability and caspase activation by determining the effects of ACA as a TRPM8 inhibitor, on oxidative stress-induced prostate cancer cell apoptosis and generation of ROS.